NCT05631951

Bone Transport Through Induced Membrane vs Conventional Bone Transport in Management of Bone Defects of Lower Limbs

Status unknown NA Last updated 9 January 2023

What this trial tests

NA trial testing bone transport through induced membrane in Bone Loss in 30 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
31 January 2023

31 January 2023

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 January 2019
Primary completion	31 January 2023
Estimated completion	31 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

• bone transport through induced membrane
• bone transport

Conditions studied

• Bone Loss — all drugs for Bone Loss →

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomised controlled comparative study comparing bone transport through induced membrane (BTM) and conventional bone transport (BT) in management of bone defects in infected non united fractures of long bones of lower limbs (femur, tibia) as regard clinical, functional outcomes and possible complications.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Scaffold Guided Bone Regeneration for the Treatment of Large Segmental Defects in Long Bones.
   Schulze F, Lang A, Schoon J, Wassilew GI, et al · · 2023 · cited 31× · PMID 36830862 · DOI 10.3390/biomedicines11020325